Skip to content

Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain Syndrome

Effects of Isokinetic Training Combined With Blood Flow Restriction in Patellofemoral Pain Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07600827
Enrollment
60
Registered
2026-05-22
Start date
2026-02-25
Completion date
2026-06-01
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Brief summary

This randomized controlled trial aims to investigate the effects of isokinetic training combined with blood flow restriction (BFR) in individuals with patellofemoral pain syndrome (PFPS).

Interventions

Participants in this group will receive supervised isokinetic muscle strength training targeting the knee musculature using an isokinetic dynamometer. Each session will last 30 minutes throughout the intervention period.

DEVICEIsokinetic Training Combined With Blood Flow Restriction

Participants in this group will receive isokinetic muscle strength training combined with blood flow restriction (BFR). BFR will be applied to the proximal thigh using a pneumatic cuff at an individualized pressure based on limb occlusion pressure. Isokinetic training will target the knee musculature using an isokinetic dynamometer under supervised conditions. Each session will last 30 minutes, with training performed multiple times per week throughout the intervention period.

DEVICEAerobic Cycling Exercise

Participants in this group will receive supervised aerobic cycling exercise using a stationary bicycle. Training will be performed at a moderate intensity for 30 minutes per session throughout the intervention period.

Sponsors

Nanjing Mingzhou Rehabilitation Hospital
Lead SponsorOTHER
Guilin institute of information technology
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Participants aged 18 to 40 years. * Clinical diagnosis of patellofemoral pain syndrome (PFPS). * Presence of anterior or retropatellar knee pain for at least 3 months. * Pain provoked by at least two activities that increase patellofemoral joint load, including squatting, stair climbing, running, jumping, prolonged sitting, or kneeling. * Average knee pain intensity of ≥3 on a 10-point visual analog scale (VAS) during aggravating activities. * Ability to participate in exercise training and attend scheduled intervention sessions. * Willingness to provide written informed consent.

Exclusion criteria

* History of knee surgery or significant trauma to the lower extremity within the previous 12 months. * Clinical evidence of other knee disorders, including ligament injury, meniscal injury, patellar instability, osteoarthritis, or tendinopathy. * Presence of neurological, cardiovascular, or systemic musculoskeletal disorders that may affect lower limb function or exercise participation. * Current participation in other structured lower extremity rehabilitation or strength training programs. * Contraindications to blood flow restriction training, including uncontrolled hypertension, vascular disease, thromboembolic disorders, or clotting abnormalities. * Use of pain-relieving injections or surgical interventions for knee pain within the previous 6 months. * Pregnancy. * Inability to complete the assessment or intervention procedures.

Design outcomes

Primary

MeasureTime frameDescription
Anterior Knee Pain Scale (AKPS)From enrollment to the end of treatment at 4 weeksThe AKPS is a validated questionnaire used to assess pain and functional limitations associated with patellofemoral pain syndrome. Scores range from 0 to 100, with higher scores indicating better knee function and fewer symptoms.

Countries

China

Contacts

CONTACTJingzhi Zhang
170787717@qq.com+86-16677137704
PRINCIPAL_INVESTIGATORZhang

Nanjing Mingzhou Rehabilitation Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026